Matches in Wikidata for { <http://www.wikidata.org/entity/Q92604045> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q92604045 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92604045 description "bài báo khoa học" @default.
- Q92604045 description "scientific article published on 13 January 2020" @default.
- Q92604045 description "wetenschappelijk artikel" @default.
- Q92604045 description "наукова стаття, опублікована 13 січня 2020" @default.
- Q92604045 name "Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma" @default.
- Q92604045 name "Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma" @default.
- Q92604045 type Item @default.
- Q92604045 label "Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma" @default.
- Q92604045 label "Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma" @default.
- Q92604045 prefLabel "Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma" @default.
- Q92604045 prefLabel "Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma" @default.
- Q92604045 P1433 Q92604045-57AE2EAE-4C45-4718-A7E8-DD5281F2B629 @default.
- Q92604045 P1476 Q92604045-7B3D97E2-F781-4D51-8718-7D1D7568EC59 @default.
- Q92604045 P2093 Q92604045-69E281B4-31BE-42B6-B42F-7D213E3834C5 @default.
- Q92604045 P2093 Q92604045-872A337A-5156-4229-BDA1-58F20E5A4C6C @default.
- Q92604045 P2093 Q92604045-8ED24E7F-6CD6-44F9-B9EA-7CD2B0FD15CC @default.
- Q92604045 P2093 Q92604045-C193F9D1-6281-4ACC-BA64-01A91C2FEA92 @default.
- Q92604045 P2093 Q92604045-CEDA0A11-E5AE-42CD-BA5D-D1D3B1D23B85 @default.
- Q92604045 P304 Q92604045-EFBCE339-F205-48E9-93A4-C3F07CB06DE1 @default.
- Q92604045 P31 Q92604045-D9CC14B2-E587-4C98-8718-D9621347F27C @default.
- Q92604045 P356 Q92604045-A4D32D97-00F8-4ADA-8868-DC54F7EEA7D3 @default.
- Q92604045 P577 Q92604045-0F0CDA97-8F05-4582-B57F-B5475C45FA35 @default.
- Q92604045 P698 Q92604045-2F33A82D-D03F-4AC4-9157-98BA2016E608 @default.
- Q92604045 P921 Q92604045-14F77700-9F54-4852-8101-1CAF360DE8BE @default.
- Q92604045 P921 Q92604045-42450FE8-4D1C-45AB-A378-A6BC90284127 @default.
- Q92604045 P921 Q92604045-DEE3E587-DE4F-4635-BA86-6AD36212EA8F @default.
- Q92604045 P921 Q92604045-FBB7CD7B-9FBF-4920-88F3-1B25F0D073CC @default.
- Q92604045 P921 Q92604045-FE5DE62B-8C80-4935-A5F9-776F28A42847 @default.
- Q92604045 P356 10428194.2020.1711902 @default.
- Q92604045 P698 31931647 @default.
- Q92604045 P1433 Q6534493 @default.
- Q92604045 P1476 "Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma" @default.
- Q92604045 P2093 "C Tom Kouroukis" @default.
- Q92604045 P2093 "Elena Mow" @default.
- Q92604045 P2093 "Jaclyn M Beca" @default.
- Q92604045 P2093 "James Keech" @default.
- Q92604045 P2093 "Kaiwan Raza" @default.
- Q92604045 P304 "1-11" @default.
- Q92604045 P31 Q13442814 @default.
- Q92604045 P356 "10.1080/10428194.2020.1711902" @default.
- Q92604045 P577 "2020-01-13T00:00:00Z" @default.
- Q92604045 P698 "31931647" @default.
- Q92604045 P921 Q136312 @default.
- Q92604045 P921 Q180983 @default.
- Q92604045 P921 Q3246818 @default.
- Q92604045 P921 Q412323 @default.
- Q92604045 P921 Q422232 @default.